As such, in Hypertension and inflammation infkammation from psoriasis, ILA inhibition has Immune support supplements for athletes led to a reduction Ajd vascular Hypedtension and is currently under evaluation in a prospective vascular inflammation trial Vascular Inflammation in Psoriasis-Secukinumab; NCT Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, Bachler JP.

Hypertension and inflammation -

Frassanito M. Silvestris F. Deregulated expression of monocyte chemoattractant protein-1 MCP-1 in arterial hypertension: role in endothelial inflammation and atheromasia.

J Hypertens. Crossref PubMed Scopus 41 Google Scholar. Hiasa K. Zhao Q. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Liu Y. Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension.

Quigley J. Olearczyk J. Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension.

Crossref PubMed Scopus 63 Google Scholar. Warner G. Hartono S. Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension. Am J Physiol Renal Physiol. Crossref PubMed Scopus 33 Google Scholar.

Osman M. Ferguson C. Ccl2 deficiency protects against chronic renal injury in murine renovascular hypertension. Sci Rep. Crossref PubMed Scopus 39 Google Scholar. Moore J. Budzyn K. Crossref PubMed Scopus 95 Google Scholar. Our group has studied the role of RANTES or CCL5 in hypertension, where it seems to have a predominant role in regulation of T-cell infiltration, particularly in the perivascular adipose tissue.

Nosalski R. Szczepaniak P. Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. FASEB J. In general, CCR5 is expressed on activated T cells in coordination with other events, like shedding of CD62L and CCR7, leading to mobilization of these cells from secondary lymphoid organs.

In contrast, CCR7 directs immune cell homing to secondary lymphoid organs. This is true for T cells and for antigen-presenting cells, like dendritic cells. In the case of antigen-presenting cells, homing to secondary lymphoid organs allows these cells to interact with T cells in lymph nodes and the spleen, where conditions are optimal for T-cell activation.

We have shown that hypertension is associated with accumulation of splenic dendritic cells that produce copious amounts of IL-6, IL, and IL-1β, compatible with such a homing event in hypertension. Fontana V. de Faria A.

DC isoketal-modified proteins activate T cells and promote hypertension. Kirabo A. Renal denervation prevents immune cell activation and renal inflammation in angiotensin II-induced hypertension. Effector T cells, macrophages, natural killer cells, and platelets express CX3CR and home to sites where the CX3C fractalkine is expressed.

Mice lacking CX3CR1 develop reduced fibrosis compared with wild type mice when subjected to DOCA-salt hypertension. Furuichi K. Sakai N. Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney.

Hypertens Res. Crossref PubMed Scopus 45 Google Scholar. Related to the function of vascular adhesion molecules and chemokines is the expression and function of matrix metalloproteinases MMPs.

These degrade matrix, allowing migration of immune cells. Barhoumi et al. recently showed that genetic deletion of MMP2 in mice completely prevents the elevation of blood pressure caused by ang II infusion.

Fraulob-Aquino J. Mian M. Matrix metalloproteinase-2 knockout prevents angiotensin II-induced vascular injury. Crossref PubMed Scopus 58 Google Scholar. Inflammasomes are multicomponent cytoplasmic complexes that promote cleavage of precursor to active forms of IL-1α,β, IL, and IL An in-depth discussion of the various subtype components of inflammasomes is beyond the scope of this review, but has been covered in depth elsewhere.

Schroder K. Inflammasome signaling and regulation of interleukin-1 family cytokines. Crossref PubMed Scopus 5 Google Scholar. Figure 2 Canonical inflammasome activation. Danger and pattern recognition pattern DAMPs and PAMPs molecules signal via Toll-like receptors to activate transcription of components of the nucleotide-binding oligomerization domain NOD -like receptor family pyrin domain containing 3 NLRP3 inflammasome and also pro-forms of interleukin IL -1 Pro-IL-1β , IL Pro-IL , and IL Pro-IL Cytokine signalling and these surface signals are transcriptionally mediated by nuclear factor kappa B NFκB.

These initial events are referred to as signal 1 or priming. Signal 2 requires additional triggering signals, including reactive oxygen species ROS , intracellular microcrystals, cellular potassium efflux, or lysosomal lysis.

These lead to inflammasome assembly and recruitment of caspase 1, which in turn cleaves pro-forms to mature IL-1β, IL, and IL Inflammasome components NLRP3 and caspase activation and recruiting CARD are depicted.

Several studies have implicated the inflammasome and its products in hypertension. Serum levels of IL-1β have been reported to be elevated in humans with essential hypertension compared with subjects who had familial hypercholesterolemia without hypertension.

Elisaf M. Bairaktari E. Tsolas O. Siamopoulos K. Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients?.

J Lab Clin Med. Abstract Full Text PDF PubMed Scopus Google Scholar. Franz S. Pruss A. Preactivated monocytes from hypertensive patients as a factor for atherosclerosis?. Abstract Full Text Full Text PDF PubMed Scopus 39 Google Scholar. Norlander A. Elijovich F. Human monocyte transcriptional profiling identifies IL receptor accessory protein and lactoferrin as novel immune targets in hypertension.

Crossref PubMed Scopus 20 Google Scholar. Krishnan et al. showed that DOCA-salt hypertension in mice is associated with increased renal mRNA levels of ASC, nucleotide-binding oligomerization domain NOD -like receptor family pyrin domain containing 3, pro-caspase 1, and pro-IL-1β.

These investigators further showed that ASC-deficient mice develop blunted hypertension, had fewer renal macrophages, and developed less renal fibrosis compared with wild type mice in response to the DOCA-salt challenge. Likewise, a pharmacological inflammasome inhibitor, MCC, reduced hypertension in wild type mice.

Dowling J. Ling Y. As mentioned, uric acid crystals can activate the canonical inflammasome, and elevated uric acid levels have been implicated in hypertension. Recently, Zambom et al. have shown that lowering uric acid levels with allopurinol prevents inflammasome activation and lowers blood pressure in a model of hypertension caused by NO inhibition and high salt-feeding in rats.

Oliveira K. Foresto-Neto O. Pathogenic role of innate immunity in a model of chronic NO inhibition associated with salt overload. Crossref PubMed Scopus 12 Google Scholar.

IL-1α and IL-1β signal through the type 1 IL-1 receptor IL1R1. Zhang et al. provided evidence that activation of this receptor promotes blood pressure elevation during ang II infusion. Mice lacking IL1R1developed blunted hypertension in response to ang II.

Anakinra, an inhibitory IL1R1 antibody, similarly reduced ang II-induced blood pressure elevation. These investigators provided evidence that IL1R1 activation prevents maturation of intrarenal macrophages that elaborate NO, and that this loss of NO signalling promotes renal sodium reuptake.

Rudemiller N. Patel M. Interleukin-1 receptor activation potentiates salt reabsorption in angiotensin II-induced hypertension via the NKCC2 co-transporter in the nephron. Cell Metab. Everett B. Thuren T. Antiinflammatory therapy with canakinumab for atherosclerotic disease.

N Engl J Med. The complement system is an ancient component of innate immunity composed of more than 50 soluble factors produced by somatic particularly hepatic cells and immune cells. Rawat A. Sharma M. Singh S.

Complement in autoimmune diseases. Clin Chim Acta. Crossref PubMed Scopus 86 Google Scholar. Joeloemsingh J. Bajema I. Trouw L.

Complement activation and regulation in rheumatic disease. Semin Immunol. Crossref PubMed Scopus 19 Google Scholar. Guntau L.

Harder M. Self versus nonself discrimination by the soluble complement regulators factor H and FHL J Immunol. Crossref PubMed Scopus 28 Google Scholar.

Lee J. Kemper C. Woodruff T. The complement receptor C5aR2: a powerful modulator of innate and adaptive immunity. Crossref PubMed Scopus 93 Google Scholar. Bagacean C. Tempescul A. Complement system: a neglected pathway in immunotherapy.

Clin Rev Allergy Immunol. Crossref PubMed Scopus 22 Google Scholar. Langer H. Complement links platelets to innate immunity. Crossref PubMed Scopus 46 Google Scholar. Figure 3 Simplified depiction of complement pathways. Complement activation can occur via 3 pathways that all lead to formation of C3a and C5a, which in turn act on cellular receptors to mediate among other effects, adhesion molecule expression, oxidative events, cell death, and leukocyte platelet aggregation.

There is substantial epidemiological evidence that complement is involved in hypertension. Engstrom et al. followed men for 15 years and reported that C3 and C4 levels were elevated in those with hypertension at baseline.

Hedblad B. Berglund G. Janzon L. Lindgarde F. Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study. J Hum Hypertens. Crossref PubMed Scopus 73 Google Scholar. Ballantyne C. Braun M. Association of the complement factor H YH polymorphism with cardiovascular disease is dependent upon hypertension status: the ARIC study.

Am J Hypertens. Mishal J. Paskin J. Resistant arterial hypertension is associated with higher blood levels of complement C3 and C-reactive protein. J Clin Hypertens Greenwich. Crossref PubMed Scopus 32 Google Scholar. Experimental studies have implicated several components of the complement pathway in the pathogenesis of hypertension.

Ruan et al. showed that C3 expression is increased in the perivascular adipose tissue of rats with DOCA-salt hypertension and that it promotes migration and differentiation of adventitial fibroblasts to myofibroblasts. Zhu D. Chen Q. Perivascular adipose tissue-derived complement 3 is required for adventitial fibroblast functions and adventitial remodeling in deoxycorticosterone acetate-salt hypertensive rats.

Complement-mediated macrophage polarization in perivascular adipose tissue contributes to vascular injury in deoxycorticosterone acetate-salt mice.

Crossref PubMed Scopus 55 Google Scholar. T-regulatory cells Tregs are a unique subset of T cells that inhibit activation of other T cells and exert anti-inflammatory effects. Kasal D. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury.

Galan M. Partyka M. Trebak M. Matrougui K. Kleinewietfeld M. Qadri F. Regulatory T cells ameliorate angiotensin II-induced cardiac damage.

Talreja D. Young K. FK binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension.

Ruan C. Deficiency of complement C3a and C5a receptors prevents angiotensin II-induced hypertension via regulatory T cells. Complement activation occurs in normal pregnancy, likely to aid in clearance of fetoplacental material, fetal DNA, and immune complexes.

Soto E. Romero R. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med. Burwick R. Fleming S. The complement system and preeclampsia. Crossref PubMed Scopus 74 Google Scholar.

Song D. Am J Reprod Immunol. Crossref PubMed Scopus 30 Google Scholar. Lund J. Wing C. Interactions between the complement and endothelin systems in normal pregnancy and following placental ischemia.

Mol Immunol. Professional antigen-presenting cells include dendritic cells, macrophages, and B cells. This process also involves other ligand receptor interactions between the T cells and antigen-presenting cells including co-stimulatory molecules like CD28 with the B7 ligands and CD27 with CD70 Fig.

We have shown that both of these interactions are important in hypertension. Chen W. Blinder Y. Xiao L. Saleh M. CD70 exacerbates blood pressure elevation and renal damage in response to repeated hypertensive stimuli.

Immune activation caused by vascular oxidation promotes fibrosis and hypertension. Figure 4 Summary of the immunological synapse. Antigen-presenting cells like dendritic cells, macrophages, and B cells process foreign proteins and modified self-proteins to antigenic peptides that are ultimately presented in major histocompatibility complexes.

This interaction between antigen-presenting cells and T cells represents a transition from innate to adaptive immunity. Figure 5 Isolevuglandin isoLG formation as a source of immune activation.

In antigen-presenting cells oxidation leads to modification of arachidonic acid and similar fatty acids and formation of isoLGs, which are highly reactive and form covalent bonds with lysines on proteins. These modified proteins are processed to peptides and presented in major histocompatibility complex I and II, and ultimately elicit T-cell activation and an immune response.

Macrophages can also act as antigen-presenting cells. De Ciuceis et al. showed that mice lacking macrophage colony stimulating factor have blunted hypertension and are protected against alterations of vascular remodelling and vascular dysfunction in response to ang II.

Amiri F. Brassard P. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury.

Ghosh S. Macrophage colony-stimulating factor and cancer: a review. Tumour Biol. This not only stimulates T cells, but also primes B cells to alter the class and quantity of antibody production. Hoch N.

Brown K. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. Sobey C. Lieu M. Obligatory role for B cells in the development of angiotensin II-dependent hypertension. Circulating myeloid cells include monocytes, neutrophils, basophils, eosinophils, erythrocytes, and platelets.

Of these, the most studied in hypertension are monocytes and monocyte-derived cells. Circulating monocytes represent a heterogenous and pleiotropic subset of leukocytes that arise from hematopoietic stem cells, which give rise to a cell known as the common myeloid precursor CMP.

CMPs were traditionally thought to sequentially yield granulocyte-monocyte precursors GMPs and monocyte dendritic cell precursors MDPs. Sasaki H. Tamura T. Transcriptional control of monocyte and macrophage development. Int Immunol. Coetzee S. Olsson A. Granulocyte-monocyte progenitors and monocyte-dendritic cell progenitors independently produce functionally distinct monocytes.

CDP, common dendritic cell progenitors; CMoP, common monocyte precursors; GP, granulocyte precursors; MP, macrophage precursors. Modified from Yanez et al.

In humans, circulating monocytes are characterized by different surface markers than those for mice, specifically on the basis of their surface expression of the Toll-like receptor 4 coreceptor CD14 and the FcγIII receptor CD16 Fig.

Flieger D. Ziegler-Heitbrock H. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Crossref PubMed Google Scholar. Fullerton J. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation.

Dayyani F. Horelt A. Ory P. Developmentally regulated IgG Fc receptors on cultured human monocytes. Ancuta P. Crowe S. Nomenclature of monocytes and dendritic cells in blood. Yamamura M.

Aita T. Arthritis Rheum. Aschenbrenner T. Wendorff H. Crossref PubMed Scopus 66 Google Scholar. Koszik F. Reininger B. J Allergy Clin Immunol.

Abstract Full Text Full Text PDF PubMed Scopus 47 Google Scholar. Di Giosia P. Ferro A. Passacquale G. Figure 7 Evolution of circulating human monocytes.

Monocytes released from the bone marrow possess the Toll-like coreceptor CD14 and little or no CD After approximately 24 hours in circulation, these cells either die, transmigrate, or acquire CD16 to be intermediate monocytes. The cells subsequently exhibit reduced CD14 expression to become nonclassical monocytes.

It is now very clear that monocytes and monocyte-derived cells play a critical role in hypertension. In a seminal study, Wenzel et al. used a diptheria toxin-based strategy to deplete monocytes and granulocytes from mice and reported that this prevented the rise in blood pressure and reduced the vascular dysfunction and the increase in vascular superoxide production caused by chronic ang II infusion.

Knorr M. Kossmann S. Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Schwenk M. Hausding M. Angiotensin II-induced vascular dysfunction depends on interferon-gamma-driven immune cell recruitment and mutual activation of monocytes and NK-cells.

Ong KL, Tso AW, Lam KS, Cheung BM. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, et al. Menopause is associated with endothelial dysfunction in women.

Kalantaridou SN, Naka KK, Papanikolaou E, Kazakos N, Kravariti M, Calis KA, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab. Kelemen M, Vaidya D, Waters DD, Howard BV, Cobb F, Younes N, et al.

Hogarth AJ, Burns J, Mackintosh AF, Mary DA. Sympathetic nerve hyperactivity of essential hypertension is lower in postmenopausal women than men. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Riegger GA.

Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Ozbey N, Sencer E, Molvalilar S, Orhan Y. Body fat distribution and cardiovascular disease risk factors in pre- and postmenopausal obese women with similar BMI. Endocr J. Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause and beyond.

J Affect Disord. Asferg C, Mogelvang R, Flyvbjerg A, Frystyk J, Jensen JS, Marott JL, et al. Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study.

Am J Hypertens. Bell BB, Rahmouni K. Leptin as a mediator of obesity-induced hypertension. Curr Obes Rep. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Google Scholar. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al.

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. Engl J Med. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, et al.

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. Kunutsor SK, Laukkanen JA. Should inflammatory pathways be targeted for the prevention and treatment of hypertension?

Download references. Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman. Department of Cardiology, Worcestershire Acute Hospitals NHS trust, Worcester, UK. You can also search for this author in PubMed Google Scholar. Correspondence to Sunil K. Reprints and permissions.

Nadar, S. Inflammation and hypertension: more evidence but is there anything new?. J Hum Hypertens 35 , — Download citation. Received : 19 October Revised : 09 November Accepted : 25 November Published : 07 December Issue Date : July Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Skip to main content Thank you for visiting nature. nature journal of human hypertension comment article. Subjects Clinical trials Prognosis.

Access through your institution. Buy or subscribe. Change institution. Learn more. References Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Article Google Scholar Beaney T, Schutte AE, Stergiou GS, Borghi C, Burger D, Charchar F, et al. Article CAS Google Scholar Lakoski SG, Cushman M, Siscovick DS, Blumenthal RS, Palmas W, Burke G, et al.

Article CAS Google Scholar Grundy SM. Article CAS Google Scholar Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Article CAS Google Scholar Li JJ, Fang CH, Hui RT.

Article CAS Google Scholar Libby P. Article CAS Google Scholar Jayedi A, Rahimi K, Bautista LE, Nazarzadeh M, Zargar MS, Shab-Bidar S. Article CAS Google Scholar Rodrigo R, Gonzalez J, Paoletto F.

Article CAS Google Scholar Tomiyama H, Ishizu T, Kohro T, Matsumoto C, Higashi Y, Takase B, et al. Article Google Scholar Nadar S, Blann AD, Lip GY. Article CAS Google Scholar Gordon JH, LaMonte MJ, Zhao J, Genco RJ, Cimato TR, Hovey KM, et al.

Article Google Scholar Ong KL, Tso AW, Lam KS, Cheung BM.

Inglammation you for visiting nature. You are Hypertensipn a browser version with limited iflammation for Hypertension and inflammation. To obtain the Hypertenison experience, qnd recommend Hypertension and inflammation use Leafy greens nutrition more up to date browser or turn off compatibility mode in Internet Explorer. In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Hypertension is one of the most prevalent risk factors for cardiovascular disease and is responsible for an excess of 10 million deaths per year worldwide [ 1 ]. Although countries around the world try to tackle the growing incidence of non-communicable diseases, these numbers remain high [ 2 ].

Hypertension and inflammation -

Liu Y. Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension. Quigley J. Olearczyk J. Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension. Crossref PubMed Scopus 63 Google Scholar.

Warner G. Hartono S. Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension. Am J Physiol Renal Physiol. Crossref PubMed Scopus 33 Google Scholar. Osman M. Ferguson C.

Ccl2 deficiency protects against chronic renal injury in murine renovascular hypertension. Sci Rep. Crossref PubMed Scopus 39 Google Scholar. Moore J. Budzyn K. Crossref PubMed Scopus 95 Google Scholar. Our group has studied the role of RANTES or CCL5 in hypertension, where it seems to have a predominant role in regulation of T-cell infiltration, particularly in the perivascular adipose tissue.

Nosalski R. Szczepaniak P. Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. FASEB J. In general, CCR5 is expressed on activated T cells in coordination with other events, like shedding of CD62L and CCR7, leading to mobilization of these cells from secondary lymphoid organs.

In contrast, CCR7 directs immune cell homing to secondary lymphoid organs. This is true for T cells and for antigen-presenting cells, like dendritic cells.

In the case of antigen-presenting cells, homing to secondary lymphoid organs allows these cells to interact with T cells in lymph nodes and the spleen, where conditions are optimal for T-cell activation. We have shown that hypertension is associated with accumulation of splenic dendritic cells that produce copious amounts of IL-6, IL, and IL-1β, compatible with such a homing event in hypertension.

Fontana V. de Faria A. DC isoketal-modified proteins activate T cells and promote hypertension. Kirabo A. Renal denervation prevents immune cell activation and renal inflammation in angiotensin II-induced hypertension. Effector T cells, macrophages, natural killer cells, and platelets express CX3CR and home to sites where the CX3C fractalkine is expressed.

Mice lacking CX3CR1 develop reduced fibrosis compared with wild type mice when subjected to DOCA-salt hypertension.

Furuichi K. Sakai N. Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney. Hypertens Res. Crossref PubMed Scopus 45 Google Scholar. Related to the function of vascular adhesion molecules and chemokines is the expression and function of matrix metalloproteinases MMPs.

These degrade matrix, allowing migration of immune cells. Barhoumi et al. recently showed that genetic deletion of MMP2 in mice completely prevents the elevation of blood pressure caused by ang II infusion. Fraulob-Aquino J. Mian M. Matrix metalloproteinase-2 knockout prevents angiotensin II-induced vascular injury.

Crossref PubMed Scopus 58 Google Scholar. Inflammasomes are multicomponent cytoplasmic complexes that promote cleavage of precursor to active forms of IL-1α,β, IL, and IL An in-depth discussion of the various subtype components of inflammasomes is beyond the scope of this review, but has been covered in depth elsewhere.

Schroder K. Inflammasome signaling and regulation of interleukin-1 family cytokines. Crossref PubMed Scopus 5 Google Scholar.

Figure 2 Canonical inflammasome activation. Danger and pattern recognition pattern DAMPs and PAMPs molecules signal via Toll-like receptors to activate transcription of components of the nucleotide-binding oligomerization domain NOD -like receptor family pyrin domain containing 3 NLRP3 inflammasome and also pro-forms of interleukin IL -1 Pro-IL-1β , IL Pro-IL , and IL Pro-IL Cytokine signalling and these surface signals are transcriptionally mediated by nuclear factor kappa B NFκB.

These initial events are referred to as signal 1 or priming. Signal 2 requires additional triggering signals, including reactive oxygen species ROS , intracellular microcrystals, cellular potassium efflux, or lysosomal lysis.

These lead to inflammasome assembly and recruitment of caspase 1, which in turn cleaves pro-forms to mature IL-1β, IL, and IL Inflammasome components NLRP3 and caspase activation and recruiting CARD are depicted.

Several studies have implicated the inflammasome and its products in hypertension. Serum levels of IL-1β have been reported to be elevated in humans with essential hypertension compared with subjects who had familial hypercholesterolemia without hypertension.

Elisaf M. Bairaktari E. Tsolas O. Siamopoulos K. Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients?. J Lab Clin Med.

Abstract Full Text PDF PubMed Scopus Google Scholar. Franz S. Pruss A. Preactivated monocytes from hypertensive patients as a factor for atherosclerosis?.

Abstract Full Text Full Text PDF PubMed Scopus 39 Google Scholar. Norlander A. Elijovich F. Human monocyte transcriptional profiling identifies IL receptor accessory protein and lactoferrin as novel immune targets in hypertension.

Crossref PubMed Scopus 20 Google Scholar. Krishnan et al. showed that DOCA-salt hypertension in mice is associated with increased renal mRNA levels of ASC, nucleotide-binding oligomerization domain NOD -like receptor family pyrin domain containing 3, pro-caspase 1, and pro-IL-1β. These investigators further showed that ASC-deficient mice develop blunted hypertension, had fewer renal macrophages, and developed less renal fibrosis compared with wild type mice in response to the DOCA-salt challenge.

Likewise, a pharmacological inflammasome inhibitor, MCC, reduced hypertension in wild type mice. Dowling J.

Ling Y. As mentioned, uric acid crystals can activate the canonical inflammasome, and elevated uric acid levels have been implicated in hypertension. Recently, Zambom et al. have shown that lowering uric acid levels with allopurinol prevents inflammasome activation and lowers blood pressure in a model of hypertension caused by NO inhibition and high salt-feeding in rats.

Oliveira K. Foresto-Neto O. Pathogenic role of innate immunity in a model of chronic NO inhibition associated with salt overload. Crossref PubMed Scopus 12 Google Scholar.

IL-1α and IL-1β signal through the type 1 IL-1 receptor IL1R1. Zhang et al. provided evidence that activation of this receptor promotes blood pressure elevation during ang II infusion. Mice lacking IL1R1developed blunted hypertension in response to ang II. Anakinra, an inhibitory IL1R1 antibody, similarly reduced ang II-induced blood pressure elevation.

These investigators provided evidence that IL1R1 activation prevents maturation of intrarenal macrophages that elaborate NO, and that this loss of NO signalling promotes renal sodium reuptake.

Rudemiller N. Patel M. Interleukin-1 receptor activation potentiates salt reabsorption in angiotensin II-induced hypertension via the NKCC2 co-transporter in the nephron. Cell Metab. Everett B. Thuren T. Antiinflammatory therapy with canakinumab for atherosclerotic disease.

N Engl J Med. The complement system is an ancient component of innate immunity composed of more than 50 soluble factors produced by somatic particularly hepatic cells and immune cells. Rawat A. Sharma M. Singh S. Complement in autoimmune diseases.

Clin Chim Acta. Crossref PubMed Scopus 86 Google Scholar. Joeloemsingh J. Bajema I. Trouw L. Complement activation and regulation in rheumatic disease. Semin Immunol. Crossref PubMed Scopus 19 Google Scholar.

Guntau L. Harder M. Self versus nonself discrimination by the soluble complement regulators factor H and FHL J Immunol.

Crossref PubMed Scopus 28 Google Scholar. Lee J. Kemper C. Woodruff T. The complement receptor C5aR2: a powerful modulator of innate and adaptive immunity. Crossref PubMed Scopus 93 Google Scholar. Bagacean C. Tempescul A. Complement system: a neglected pathway in immunotherapy. Clin Rev Allergy Immunol.

Crossref PubMed Scopus 22 Google Scholar. Langer H. Complement links platelets to innate immunity. Crossref PubMed Scopus 46 Google Scholar. Figure 3 Simplified depiction of complement pathways. Complement activation can occur via 3 pathways that all lead to formation of C3a and C5a, which in turn act on cellular receptors to mediate among other effects, adhesion molecule expression, oxidative events, cell death, and leukocyte platelet aggregation.

There is substantial epidemiological evidence that complement is involved in hypertension. Engstrom et al. followed men for 15 years and reported that C3 and C4 levels were elevated in those with hypertension at baseline. Hedblad B. Berglund G. Janzon L. Lindgarde F. Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study.

J Hum Hypertens. Crossref PubMed Scopus 73 Google Scholar. Ballantyne C. Braun M. Association of the complement factor H YH polymorphism with cardiovascular disease is dependent upon hypertension status: the ARIC study.

Am J Hypertens. Mishal J. Paskin J. Resistant arterial hypertension is associated with higher blood levels of complement C3 and C-reactive protein. J Clin Hypertens Greenwich.

Crossref PubMed Scopus 32 Google Scholar. Experimental studies have implicated several components of the complement pathway in the pathogenesis of hypertension.

Ruan et al. showed that C3 expression is increased in the perivascular adipose tissue of rats with DOCA-salt hypertension and that it promotes migration and differentiation of adventitial fibroblasts to myofibroblasts.

Zhu D. Chen Q. Perivascular adipose tissue-derived complement 3 is required for adventitial fibroblast functions and adventitial remodeling in deoxycorticosterone acetate-salt hypertensive rats.

Complement-mediated macrophage polarization in perivascular adipose tissue contributes to vascular injury in deoxycorticosterone acetate-salt mice. Crossref PubMed Scopus 55 Google Scholar.

T-regulatory cells Tregs are a unique subset of T cells that inhibit activation of other T cells and exert anti-inflammatory effects. Kasal D. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury.

Galan M. Partyka M. Trebak M. Matrougui K. Kleinewietfeld M. Qadri F. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Talreja D. Young K. FK binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension.

Ruan C. Deficiency of complement C3a and C5a receptors prevents angiotensin II-induced hypertension via regulatory T cells. Complement activation occurs in normal pregnancy, likely to aid in clearance of fetoplacental material, fetal DNA, and immune complexes.

Soto E. Romero R. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med. Burwick R. Fleming S. The complement system and preeclampsia.

Crossref PubMed Scopus 74 Google Scholar. Song D. Am J Reprod Immunol. Crossref PubMed Scopus 30 Google Scholar. Lund J. Wing C. Interactions between the complement and endothelin systems in normal pregnancy and following placental ischemia.

Mol Immunol. Professional antigen-presenting cells include dendritic cells, macrophages, and B cells. This process also involves other ligand receptor interactions between the T cells and antigen-presenting cells including co-stimulatory molecules like CD28 with the B7 ligands and CD27 with CD70 Fig.

We have shown that both of these interactions are important in hypertension. Chen W. Blinder Y. Xiao L. Saleh M. CD70 exacerbates blood pressure elevation and renal damage in response to repeated hypertensive stimuli.

Immune activation caused by vascular oxidation promotes fibrosis and hypertension. Figure 4 Summary of the immunological synapse. Antigen-presenting cells like dendritic cells, macrophages, and B cells process foreign proteins and modified self-proteins to antigenic peptides that are ultimately presented in major histocompatibility complexes.

This interaction between antigen-presenting cells and T cells represents a transition from innate to adaptive immunity. Figure 5 Isolevuglandin isoLG formation as a source of immune activation.

In antigen-presenting cells oxidation leads to modification of arachidonic acid and similar fatty acids and formation of isoLGs, which are highly reactive and form covalent bonds with lysines on proteins.

These modified proteins are processed to peptides and presented in major histocompatibility complex I and II, and ultimately elicit T-cell activation and an immune response. Macrophages can also act as antigen-presenting cells.

De Ciuceis et al. showed that mice lacking macrophage colony stimulating factor have blunted hypertension and are protected against alterations of vascular remodelling and vascular dysfunction in response to ang II. Amiri F. Brassard P.

Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury.

Ghosh S. Macrophage colony-stimulating factor and cancer: a review. Tumour Biol. This not only stimulates T cells, but also primes B cells to alter the class and quantity of antibody production.

Hoch N. Brown K. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. Sobey C. Lieu M.

Obligatory role for B cells in the development of angiotensin II-dependent hypertension. Circulating myeloid cells include monocytes, neutrophils, basophils, eosinophils, erythrocytes, and platelets.

Of these, the most studied in hypertension are monocytes and monocyte-derived cells. Circulating monocytes represent a heterogenous and pleiotropic subset of leukocytes that arise from hematopoietic stem cells, which give rise to a cell known as the common myeloid precursor CMP.

CMPs were traditionally thought to sequentially yield granulocyte-monocyte precursors GMPs and monocyte dendritic cell precursors MDPs.

Sasaki H. Tamura T. Transcriptional control of monocyte and macrophage development. Int Immunol. Coetzee S. Olsson A. Granulocyte-monocyte progenitors and monocyte-dendritic cell progenitors independently produce functionally distinct monocytes.

CDP, common dendritic cell progenitors; CMoP, common monocyte precursors; GP, granulocyte precursors; MP, macrophage precursors. Modified from Yanez et al. In humans, circulating monocytes are characterized by different surface markers than those for mice, specifically on the basis of their surface expression of the Toll-like receptor 4 coreceptor CD14 and the FcγIII receptor CD16 Fig.

Flieger D. Ziegler-Heitbrock H. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Crossref PubMed Google Scholar. Fullerton J. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation.

Dayyani F. Horelt A. Ory P. Developmentally regulated IgG Fc receptors on cultured human monocytes. Ancuta P. Crowe S. Nomenclature of monocytes and dendritic cells in blood.

Yamamura M. Aita T. Arthritis Rheum. Aschenbrenner T. Wendorff H. Crossref PubMed Scopus 66 Google Scholar. Koszik F. Reininger B. J Allergy Clin Immunol. Abstract Full Text Full Text PDF PubMed Scopus 47 Google Scholar. Di Giosia P. Ferro A. Passacquale G. Figure 7 Evolution of circulating human monocytes.

Monocytes released from the bone marrow possess the Toll-like coreceptor CD14 and little or no CD After approximately 24 hours in circulation, these cells either die, transmigrate, or acquire CD16 to be intermediate monocytes.

The cells subsequently exhibit reduced CD14 expression to become nonclassical monocytes. It is now very clear that monocytes and monocyte-derived cells play a critical role in hypertension.

In a seminal study, Wenzel et al. used a diptheria toxin-based strategy to deplete monocytes and granulocytes from mice and reported that this prevented the rise in blood pressure and reduced the vascular dysfunction and the increase in vascular superoxide production caused by chronic ang II infusion.

Knorr M. Kossmann S. Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Schwenk M. Hausding M. Angiotensin II-induced vascular dysfunction depends on interferon-gamma-driven immune cell recruitment and mutual activation of monocytes and NK-cells.

In previous years, it was thought that the transmigration of monocytes across the endothelium invariably led to transformation of these cells to either an inflammatory macrophage or a monocyte-derived dendritic cell and monocytes served as the major, if not the only source of these tissue-residing cells.

This concept has been modified by 2 major observations. First, it is now clear that populations of specialized macrophages reside in peripheral tissues that have developed in the yolk sac rather than from blood-borne monocytes. Chow A. Noizat C. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes.

Tarling J. The proliferation kinetics of pulmonary alveolar macrophages. As such, in patient suffering from psoriasis, ILA inhibition has also led to a reduction in vascular inflammation and is currently under evaluation in a prospective vascular inflammation trial Vascular Inflammation in Psoriasis-Secukinumab; NCT Consequently, knowing that all of these immunotherapeutic approaches reduce vascular inflammation or restore vascular functions, they could all be potential therapeutic options to prevent hypertension and its associated cerebrovascular risks.

Emerging evidence from preclinical studies points to a strong relationship between hypertension, altered cerebrovascular functions, neuroinflammation, and brain dysfunctions.

Hypertension, through systemic inflammation, can alter the structure and function of cerebral blood vessels and therefore impair the fundamental mechanisms responsible to maintain brain homeostasis. Indeed, oxidative stress and inflammation induced by hypertension are key contributors to neurovascular and endothelial dysfunctions.

However, many questions remain unresolved. For example, which animal model would allow better translational discoveries about the immune role in cerebrovascular diseases in hypertension? Also, are mechanical and circulating proinflammatory factors responsible for cerebrovascular impairments in hypertension, or do neurogenic factors induce hypertension in parallel of cerebrovascular impairments?

Considering the importance of the immune system in physiological functions and for protecting against pathogens, which element should be targeted to optimize beneficial effects in hypertensive patients?

Even though promising results in clinical trials have shown a reduction in systemic inflammation and related vascular dysfunctions, the impact of immunotherapies on brain inflammation and associated cerebrovascular complications need a profound evaluation.

Immunomodulating drugs could be a potential therapeutic approach against hypertension-associated cerebrovascular disorders, such as stroke, vascular cognitive impairment, and AD.

Assistance with manuscript revision was provided by Diane Vallerand. Figures were created with BioRender. Hélène Girouard was supported by the Fonds de recherche du Québec—Santé FRQS; Qiu C , Winblad B , Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia.

Lancet Neurol ; 4 : — Google Scholar. Montecucco F , Pende A , Quercioli A , Mach F. Inflammation in the pathophysiology of essential hypertension. J Nephrol ; 24 : 23 — Csiszar A , Tarantini S , Fülöp GA , Kiss T , Valcarcel-Ares MN , Galvan V , Ungvari Z , Yabluchanskiy A.

Geroscience ; 39 : — Granger DN , Rodrigues SF , Yildirim A , Senchenkova EY. Microvascular responses to cardiovascular risk factors. Microcirculation ; 17 : — Liddelow SA , Guttenplan KA , Clarke LE , Bennett FC , Bohlen CJ , Schirmer L , Bennett ML , Münch AE , Chung WS , Peterson TC , Wilton DK , Frouin A , Napier BA , Panicker N , Kumar M , Buckwalter MS , Rowitch DH , Dawson VL , Dawson TM , Stevens B , Barres BA.

Neurotoxic reactive astrocytes are induced by activated microglia. Nature ; : — Auton Neurosci ; : 71 — Koizumi T , Taguchi K , Mizuta I , Toba H , Ohigashi M , Onishi O , Ikoma K , Miyata S , Nakata T , Tanaka M , Foulquier S , Steinbusch HWM , Mizuno T. Transiently proliferating perivascular microglia harbor M1 type and precede cerebrovascular changes in a chronic hypertension model.

J Neuroinflammation ; 16 : Carnevale D , Lembo G. Biochem Soc Trans ; 39 : — Benicky J , Sánchez-Lemus E , Pavel J , Saavedra JM. Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery. Cell Mol Neurobiol ; 29 : — Drouin A , Bolduc V , Thorin-Trescases N , Bélanger É , Fernandes P , Baraghis E , Lesage F , Gillis MA , Villeneuve L , Hamel E , Ferland G , Thorin E.

Catechin treatment improves cerebrovascular flow-mediated dilation and learning abilities in atherosclerotic mice. Am J Physiol Heart Circ Physiol ; : H — H Meissner A , Minnerup J , Soria G , Planas AM. Structural and functional brain alterations in a murine model of angiotensin II-induced hypertension.

J Neurochem ; : — Banks WA. Blood—brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des ; 11 : — McColl BW , Rothwell NJ , Allan SM.

Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice.

J Neurosci ; 28 : — Hirooka Y. Sympathetic activation in hypertension: Importance of the central nervous system. Am J Hypertens ; 33 : — Obari D , Ozcelik S , Girouard H , Hamel E. Cognitive dysfunction and dementia in animal models of hypertension. In Girouard H ed , Hypertension and the Brain as an End-Organ Target.

Springer : New York , , pp 71 — Google Preview. Zicha J , Kunes J. Ontogenetic aspects of hypertension development: analysis in the rat. Physiol Rev ; 79 : — Tayebati SK , Tomassoni D , Amenta F.

Neuroinflammatory markers in spontaneously hypertensive rat brain: an immunohistochemical study. CNS Neurol Disord Drug Targets ; 15 : — Inflammation of different tissues in spontaneously hypertensive rats. Sheng Li Xue Bao ; 58 : — Tomassoni D , Avola R , Di Tullio MA , Sabbatini M , Vitaioli L , Amenta F.

Increased expression of glial fibrillary acidic protein in the brain of spontaneously hypertensive rats. Clin Exp Hypertens ; 26 : — Waki H , Gouraud SS , Maeda M , Raizada MK , Paton JF. Contributions of vascular inflammation in the brainstem for neurogenic hypertension.

Respir Physiol Neurobiol ; : — Sabbatini M , Catalani A , Consoli C , Marletta N , Tomassoni D , Avola R. The hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia? Mech Ageing Dev ; : — Chiba T , Itoh T , Tabuchi M , Nakazawa T , Satou T.

Interleukin-1β accelerates the onset of stroke in stroke-prone spontaneously hypertensive rats. Mediators Inflamm ; : Gelderblom M , Weymar A , Bernreuther C , Velden J , Arunachalam P , Steinbach K , Orthey E , Arumugam TV , Leypoldt F , Simova O , Thom V , Friese MA , Prinz I , Hölscher C , Glatzel M , Korn T , Gerloff C , Tolosa E , Magnus T.

Neutralization of the IL axis diminishes neutrophil invasion and protects from ischemic stroke. Blood ; : — Saleh MA , Norlander AE , Madhur MS.

Inhibition of interleukin A but not interleukinF signaling lowers blood pressure and reduces end-organ inflammation in angiotensin II-induced hypertension.

JACC Basic Transl Sci ; 1 : — Lockshin B , Balagula Y , Merola JF. Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis. J Am Acad Dermatol ; 79 : — Chronically infused angiotensin II induces depressive-like behavior via microglia activation. Sci Rep ; 10 : Age-related changes in hypertensive brain damage in the hippocampi of spontaneously hypertensive rats.

Mol Med Rep ; 13 : — Kaiser D , Weise G , Möller K , Scheibe J , Pösel C , Baasch S , Gawlitza M , Lobsien D , Diederich K , Minnerup J , Kranz A , Boltze J , Wagner DC. Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease.

Acta Neuropathol Commun ; 2 : Ando H , Zhou J , Macova M , Imboden H , Saavedra JM. Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats. Stroke ; 35 : — Santisteban MM , Ahmari N , Carvajal JM , Zingler MB , Qi Y , Kim S , Joseph J , Garcia-Pereira F , Johnson RD , Shenoy V , Raizada MK , Zubcevic J.

Involvement of bone marrow cells and neuroinflammation in hypertension. Circ Res ; 2 : — Avolio E , Pasqua T , Di Vito A , Fazzari G , Cardillo G , Alò R , Cerra MC , Barni T , Angelone T , Canonaco M.

Role of brain neuroinflammatory factors on hypertension in the spontaneously hypertensive rat. Neuroscience ; : — Möller K , Pösel C , Kranz A , Schulz I , Scheibe J , Didwischus N , Boltze J , Weise G , Wagner D-C.

Arterial hypertension aggravates innate immune responses after experimental stroke. Front Cell Neurosci ; 9 : 1 — Brocca ME , Pietranera L , Meyer M , Lima A , Roig P , de Kloet ER , De Nicola AF.

Mineralocorticoid receptor associates with pro-inflammatory bias in the hippocampus of spontaneously hypertensive rats. J Neuroendocrinol ; 29 7 : 1 — Hojná S , Kuneš J , Zicha J.

Alterations of NO synthase isoforms in brain and kidney of rats with genetic and salt hypertension. Physiol Res ; 59 : — Vaziri ND , Ni Z , Oveisi F , Trnavsky-Hobbs DL. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension ; 36 : — Pelisch N , Hosomi N , Ueno M , Nakano D , Hitomi H , Mogi M , Shimada K , Kobori H , Horiuchi M , Sakamoto H , Matsumoto M , Kohno M , Nishiyama A.

Blockade of AT1 receptors protects the blood—brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats. Am J Hypertens ; 24 : — Marks L , Carswell HV , Peters EE , Graham DI , Patterson J , Dominiczak AF , Macrae IM.

Characterization of the microglial response to cerebral ischemia in the stroke-prone spontaneously hypertensive rat. Hypertension ; 38 : — Xia H , Sriramula S , Chhabra KH , Lazartigues E. Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.

Circ Res ; : — Protective effects of D-Limonene against transient cerebral ischemia in stroke-prone spontaneously hypertensive rats. Exp Ther Med ; 15 : — Cheng MC , Pan TM. Prevention of hypertension-induced vascular dementia by Lactobacillus paracasei subsp.

paracasei NTU fermented products. Pharm Biol ; 55 : — Iyonaga T , Shinohara K , Mastuura T , Hirooka Y , Tsutsui H. Brain perivascular macrophages contribute to the development of hypertension in stroke-prone spontaneously hypertensive rats via sympathetic activation. Hypertens Res ; 43 : 99 — Abiodun OA , Ola MS.

Role of brain renin angiotensin system in neurodegeneration: an update. Saudi J Biol Sci ; 27 : — Johanson C , Stopa E , McMillan P , Roth D , Funk J , Krinke G. Toxicol Pathol ; 39 : — Saavedra JM.

Brain and pituitary angiotensin. Endocr Rev ; 13 : — Allen AM , Zhuo J , Mendelsohn FA. Localization and function of angiotensin AT1 receptors. Am J Hypertens ; 13 : 31S — 38S. Mol Med Rep ; 12 : — Biancardi VC , Stranahan AM , Krause EG , de Kloet AD , Stern JE.

Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus. Glass MJ , Huang J , Speth RC , Iadecola C , Pickel VM. Angiotensin II AT-1A receptor immunolabeling in rat medial nucleus tractus solitarius neurons: subcellular targeting and relationships with catecholamines.

Sumners C , Alleyne A , Rodríguez V , Pioquinto DJ , Ludin JA , Kar S , Winder Z , Ortiz Y , Liu M , Krause EG , de Kloet AD. Brain angiotensin type-1 and type-2 receptors: cellular locations under normal and hypertensive conditions. Hypertens Res ; 43 : — Faraco G , Sugiyama Y , Lane D , Garcia-Bonilla L , Chang H , Santisteban MM , Racchumi G , Murphy M , Van Rooijen N , Anrather J , Iadecola C.

Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. J Clin Invest ; : — Zhang M , Mao Y , Ramirez SH , Tuma RF , Chabrashvili T. Angiotensin II induced cerebral microvascular inflammation and increased blood—brain barrier permeability via oxidative stress.

Iulita MF , Vallerand D , Beauvillier M , Haupert N , A Ulysse C , Gagné A , Vernoux N , Duchemin S , Boily M , Tremblay MÈ , Girouard H.

Differential effect of angiotensin II and blood pressure on hippocampal inflammation in mice. J Neuroinflammation ; 15 : Capone C , Faraco G , Park L , Cao X , Davisson RL , Iadecola C. The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension.

Biancardi VC , Son SJ , Ahmadi S , Filosa JA , Stern JE. Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood—brain barrier. Hypertension ; 63 : — Jiang E , Chapp AD , Fan Y , Larson RA , Hahka T , Huber MJ , Yan J , Chen Q-H , Shan Z.

Expression of proinflammatory cytokines is upregulated in the hypothalamic paraventricular nucleus of Dahl salt-sensitive hypertensive rats. Front Physiol ; 9 : Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension.

Circulation ; 53 : — Barhoumi T , Kasal DA , Li MW , Shbat L , Laurant P , Neves MF , Paradis P , Schiffrin EL. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension ; 57 : — Kassan M , Galan M , Partyka M , Trebak M , Matrougui K.

Arterioscler Thromb Vasc Biol ; 31 : — Kinzenbaw DA , Chu Y , Peña Silva RA , Didion SP , Faraci FM. Interleukin protects against aging-induced endothelial dysfunction.

Physiol Rep ; 1 : e Faraco G , Brea D , Garcia-Bonilla L , Wang G , Racchumi G , Chang H , Buendia I , Santisteban MM , Segarra SG , Koizumi K , Sugiyama Y , Murphy M , Voss H , Anrather J , Iadecola C. Dietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated TH17 response.

Nat Neurosci ; 21 : — Fujita M , Ando K , Nagae A , Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension ; 50 : — Rodrigues SF , Granger DN. Cerebral microvascular inflammation in DOCA salt-induced hypertension: role of angiotensin II and mitochondrial superoxide.

J Cereb Blood Flow Metab ; 32 2 : — Santisteban MM , Ahn SJ , Lane D , Faraco G , Garcia-Bonilla L , Racchumi G , Poon C , Schaeffer S , Segarra SG , Körbelin J , Anrather J , Iadecola C. Endothelium-macrophage crosstalk mediates blood—brain barrier dysfunction in hypertension. Hypertension ; 76 : — Wakisaka Y , Miller JD , Chu Y , Baumbach GL , Wilson S , Faraci FM , Sigmund CD , Heistad DD.

Oxidative stress through activation of NAD P H oxidase in hypertensive mice with spontaneous intracranial hemorrhage. J Cereb Blood Flow Metab ; 28 : — Shen XZ , Li Y , Li L , Shah KH , Bernstein KE , Lyden P , Shi P.

Microglia participate in neurogenic regulation of hypertension. Hypertension Dallas, Tex: ; 66 2 : — Dinh QN , Young MJ , Evans MA , Drummond GR , Sobey CG , Chrissobolis S. Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor.

Brain Res ; : — Chrissobolis S , Drummond GR , Faraci FM , Sobey CG. Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation. J Hypertens ; 32 : — Merrill DC , Thompson MW , Carney CL , Granwehr BP , Schlager G , Robillard JE , Sigmund CD.

Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes.

J Clin Invest ; 97 : — Davisson RL , Yang G , Beltz TG , Cassell MD , Johnson AK , Sigmund CD. The brain renin—angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res ; 83 : — Merrill DC , Granwehr BP , Davis DR , Sigmund CD.

Use of transgenic and gene-targeted mice to model the genetic basis of hypertensive disorders. Proc Assoc Am Physicians ; : — Baumbach GL , Sigmund CD , Faraci FM. Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen.

Hypertension ; 41 : 50 — Baumbach GL , Heistad DD. Cerebral circulation in chronic arterial hypertension. Hypertension ; 12 : 89 — Laurent S , Boutouyrie P , Lacolley P.

Structural and genetic bases of arterial stiffness. Hypertension ; 45 : — Spät A , Hunyady L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways.

Physiol Rev ; 84 : — Han F , Ozawa H , Matsuda KI , Lu H , De Kloet ER , Kawata M. Changes in the expression of corticotrophin-releasing hormone, mineralocorticoid receptor and glucocorticoid receptor mRNAs in the hypothalamic paraventricular nucleus induced by fornix transection and adrenalectomy.

J Neuroendocrinol ; 19 : — Rigsby CS , Burch AE , Ogbi S , Pollock DM , Dorrance AM. Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists.

Am J Physiol Regul Integr Comp Physiol ; : R — R Gomez-Sanchez EP. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology ; : — Kageyama Y , Bravo EL. Hypertensive mechanisms associated with centrally administered aldosterone in dogs.

Hypertension ; 11 : — Francis J , Beltz T , Johnson AK , Felder RB. Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor-alpha in normal rats. Dahl LK , Heine M , Tassinari L. Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion.

Jiang E , Chapp AD , Fan Y , Larson RA , Hahka T , Huber MJ , Yan J , Chen QH , Shan Z. Ueno Y , Mohara O , Brosnihan KB , Ferrario CM. Characteristics of hormonal and neurogenic mechanisms of deoxycorticosterone-induced hypertension. Hypertension ; 11 : I — I Tynan RJ , Naicker S , Hinwood M , Nalivaiko E , Buller KM , Pow DV , Day TA , Walker FR.

Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav Immun ; 24 : — Gutkind JS , Kurihara M , Saavedra JM. Increased angiotensin II receptors in brain nuclei of DOCA-salt hypertensive rats.

Am J Physiol ; : H — H Schenk J , McNeill JH. The pathogenesis of DOCA-salt hypertension. J Pharmacol Toxicol Methods ; 27 : — Matthews KA , Katholi CR , McCreath H , Whooley MA , Williams DR , Zhu S , Markovitz JH.

Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation ; : 74 — Marvar PJ , Vinh A , Thabet S , Lob HE , Geem D , Ressler KJ , Harrison DG.

T lymphocytes and vascular inflammation contribute to stress-dependent hypertension. Biol Psychiatry ; 71 : — Chronic stress decreases cerebrovascular responses during rat hindlimb electrical stimulation.

Front Neurosci ; 9 : Behav Brain Res ; : — Wilson RS , Arnold SE , Schneider JA , Li Y , Bennett DA. Chronic distress, age-related neuropathology, and late-life dementia. Psychosom Med ; 69 : 47 — Black PH. Stress and the inflammatory response: a review of neurogenic inflammation.

Brain Behav Immun ; 16 : — Yaffe K , Lindquist K , Penninx BW , Simonsick EM , Pahor M , Kritchevsky S , Launer L , Kuller L , Rubin S , Harris T.

Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology ; 61 : 76 — Braszko JJ , Wincewicz D , Jakubów P. Candesartan prevents impairment of recall caused by repeated stress in rats.

Psychopharmacology Berl ; : — Don-Doncow N , Vanherle L , Zhang Y , Meissner A. T-cell accumulation in the hypertensive brain: a role for sphingosinephosphate-mediated chemotaxis. Int J Mol Sci ; 20 3 : Role of neuroinflammation in hypertension-induced brain amyloid pathology.

Neurobiol Aging ; 33 : e19 — Poulet R , Gentile MT , Vecchione C , Distaso M , Aretini A , Fratta L , Russo G , Echart C , Maffei A , De Simoni MG , Lembo G.

Acute hypertension induces oxidative stress in brain tissues. J Cereb Blood Flow Metab ; 26 : — Sadekova N , Iulita MF , Vallerand D , Muhire G , Bourmoum M , Claing A , Girouard H. Arterial stiffness induced by carotid calcification leads to cerebral gliosis mediated by oxidative stress.

J Hypertens ; 36 : — Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature. Hypertension Dallas, Tex: ; 60 : — Mestas J , Hughes CC. Of mice and not men: differences between mouse and human immunology.

J Immunol ; : — Daneman R. The blood—brain barrier in health and disease. Ann Neurol ; 72 : — Maktabi MA , Heistad DD , Faraci FM.

Effects of central and intravascular angiotensin I and II on the choroid plexus. Am J Physiol ; : R — R Villaseñor R , Ozmen L , Messaddeq N , Grüninger F , Loetscher H , Keller A , Betsholtz C , Freskgård PO , Collin L. Trafficking of endogenous immunoglobulins by endothelial cells at the blood—brain barrier.

Sci Rep ; 6 : Korn T , Kallies A. T cell responses in the central nervous system. Nat Rev Immunol ; 17 : — Baruch K , Deczkowska A , Rosenzweig N , Tsitsou-Kampeli A , Sharif AM , Matcovitch-Natan O , Kertser A , David E , Amit I , Schwartz M.

Nat Med ; 22 : — Chodobski A , Szmydynger-Chodobska J , Johanson CE. Angiotensin II regulates choroid plexus blood flow by interacting with the sympathetic nervous system and nitric oxide. Meningeal lymphatic vessels regulate brain tumor drainage and immunity.

Cell Res ; 30 : — Mestre H , Mori Y , Nedergaard M. Trends Neurosci ; 43 : — Mestre H , Tithof J , Du T , Song W , Peng W , Sweeney AM , Olveda G , Thomas JH , Nedergaard M , Kelley DH.

Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension. Nat Commun ; 9 : Hunt BJ , Jurd KM. Endothelial cell activation. A central pathophysiological process.

BMJ Clinical Research ed ; : — Ludewig P , Winneberger J , Magnus T. The cerebral endothelial cell as a key regulator of inflammatory processes in sterile inflammation.

J Neuroimmunol ; : 38 — Zhou H , Andonegui G , Wong CH , Kubes P. Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation. CXCR2 is essential for cerebral endothelial activation and leukocyte recruitment during neuroinflammation.

J Neuroinflamm ; 12 : Ludewig P , Sedlacik J , Gelderblom M , Bernreuther C , Korkusuz Y , Wagener C , Gerloff C , Fiehler J , Magnus T , Horst AK.

Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMPmediated blood—brain-barrier breakdown in a mouse model for ischemic stroke. Reglero-Real N , Colom B , Bodkin JV , Nourshargh S.

Endothelial cell junctional adhesion molecules: role and regulation of expression in inflammation. Arterioscler Thromb Vasc Biol ; 36 : — Pan W , Kastin AJ , Daniel J , Yu C , Baryshnikova LM , von Bartheld CS. TNFalpha trafficking in cerebral vascular endothelial cells.

J Neuroimmunol ; : 47 — Fujimoto K. Pericyte—endothelial gap junctions in developing rat cerebral capillaries: a fine structural study. Anat Rec ; : — Liu S , Agalliu D , Yu C , Fisher M. The role of pericytes in blood—brain barrier function and stroke. Curr Pharm Des ; 18 : — What is a pericyte?

J Cereb Blood Flow Metab ; 36 : — Hirunpattarasilp C , Attwell D , Freitas F. The role of pericytes in brain disorders: from the periphery to the brain.

Capillary pericytes regulate cerebral blood flow in health and disease. Nature ; : 55 — Sweeney MD , Ayyadurai S , Zlokovic BV. Pericytes of the neurovascular unit: key functions and signaling pathways.

Nat Neurosci ; 19 : — Berthiaume AA , Hartmann DA , Majesky MW , Bhat NR , Shih AY. Pericyte structural remodeling in cerebrovascular health and homeostasis.

Front Aging Neurosci ; 10 : Activated microglia induce the production of reactive oxygen species and promote apoptosis of co-cultured retinal microvascular pericytes. Graefes Arch Clin Exp Ophthalmol ; : — Al Ahmad A , Gassmann M , Ogunshola OO. Maintaining blood—brain barrier integrity: pericytes perform better than astrocytes during prolonged oxygen deprivation.

J Cell Physiol ; : — Abbott NJ , Rönnbäck L , Hansson E. Astrocyte—endothelial interactions at the blood—brain barrier. Nat Rev Neurosci ; 7 1 : 41 — Igarashi Y , Utsumi H , Chiba H , Yamada-Sasamori Y , Tobioka H , Kamimura Y , Furuuchi K , Kokai Y , Nakagawa T , Mori M , Sawada N.

Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood—brain barrier. Biochem Biophys Res Commun ; : — Heinemann U , Kaufer D , Friedman A.

Blood—brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsy. Glia ; 60 : — Prat A , Biernacki K , Wosik K , Antel JP.

Glial cell influence on the human blood—brain barrier. Glia ; 36 : — Lee SW , Kim WJ , Choi YK , Song HS , Son MJ , Gelman IH , Kim YJ , Kim KW. SSeCKS regulates angiogenesis and tight junction formation in blood—brain barrier.

Nat Med ; 9 : — Michinaga S , Koyama Y. Dual roles of astrocyte-derived factors in regulation of blood—brain barrier function after brain damage.

Lécuyer M-A , Kebir H , Prat A. Glial influences on BBB functions and molecular players in immune cell trafficking.

Biochimica et Biophysica Acta BBA - Molecular Basis of Disease ; 3 : — Cipollini V , Anrather J , Orzi F , Iadecola C. Th17 and cognitive impairment: Possible mechanisms of action. Front Neuroanat ; 13 : Mantle JL , Lee KH.

A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-α and IL-6 in an iPSC-based blood—brain barrier model. Neurobiol Dis ; : — De Silva TM , Faraci FM. In Caplan LR , Biller J , Leary MC , Lo EH, Thomas AJ , Yenari M , et al. eds , Primer on Cerebrovascular Diseases, 2nd edn.

Academic Press : San Diego , , pp — Sokolova IA , Manukhina EB , Blinkov SM , Koshelev VB , Pinelis VG , Rodionov IM. Rarefication of the arterioles and capillary network in the brain of rats with different forms of hypertension.

Microvasc Res ; 30 : 1 — 9. Paiardi S , Rodella LF , De Ciuceis C , Porteri E , Boari GE , Rezzani R , Rizzardi N , Platto C , Tiberio GA , Giulini SM , Rizzoni D , Agabiti-Rosei E.

Immunohistochemical evaluation of microvascular rarefaction in hypertensive humans and in spontaneously hypertensive rats. Clin Hemorheol Microcirc ; 42 : — Yamakawa H , Jezova M , Ando H , Saavedra JM.

Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition.

J Cereb Blood Flow Metab ; 23 : — Ouk M , Wu CY , Rabin JS , Jackson A , Edwards JD , Ramirez J , Masellis M , Swartz RH , Herrmann N , Lanctôt KL , Black SE , Swardfager W. The use of angiotensin-converting enzyme inhibitors vs.

Alzheimers Res Ther ; 13 : Exp Neurol ; : — Kasparová S , Brezová V , Valko M , Horecký J , Mlynárik V , Liptaj T , Vancová O , Ulicná O , Dobrota D. Study of the oxidative stress in a rat model of chronic brain hypoperfusion.

Neurochem Int ; 46 : — Won JS , Kim J , Annamalai B , Shunmugavel A , Singh I , Singh AK. Protective role of S-nitrosoglutathione GSNO against cognitive impairment in rat model of chronic cerebral hypoperfusion.

J Alzheimers Dis ; 34 : — Catalpol promotes oligodendrocyte survival and oligodendrocyte progenitor differentiation via the Akt signaling pathway in rats with chronic cerebral hypoperfusion.

Brain Res ; : 27 —

Metrics details. A Correction to this Hyprrtension was published on 08 July The relationship between inflammation inflamamtion blood pressure BP has Xnd studied mainly in Anxiety support and guidance general Hypertension and inflammation. In this study, we examined the association between inflammation and BP across a broader range of inflammation observed in rheumatoid arthritis RA and non-RA outpatients. We studied subjects from a tertiary care outpatient population with C-reactive protein CRP and BP measured on the same date in —; RA outpatients were identified using a validated algorithm. However, the mechanistic link between hypertension and neurodegenerative diseases remains to Saltwater Fish Species understood. Recent evidence Hypertension and inflammation that inflammation is a common pathophysiological inflammstion for both hypertension and neurodegenerative Fat burners for rapid weight loss. Low-grade chronic inflammation at Antifungal remedies for skin systemic and central Hypdrtension system inflammatiin is now recognized Fat burners for rapid weight loss infalmmation to the physiopathology of hypertension. This review speculates that inflammation represents a mediator between hypertension and neurodegenerative diseases, either by a decrease in cerebral blood flow or a disruption of the blood—brain barrier which will, in turn, let inflammatory cells and neurotoxic molecules enter the brain parenchyma. This may impact brain functions including cognition and contribute to neurodegenerative diseases. This review will thus discuss the relationship between hypertension, systemic inflammation, cerebrovascular functions, neuroinflammation, and brain dysfunctions. The potential clinical future of immunotherapies against hypertension and associated cerebrovascular risks will also be presented.

Video

Pulmonary hypertension, inflammation, and immune response: the long way from thought to action